The cells of the allergic response: Mast cells, basophils, and eosinophils

JAMA

Volumn 278, Issue 22, 1997, Pages 1815-1822

  Costa, John J ^a   Weller, Peter F ^a   Galli, Stephen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID HYDROLASE; CARBOXYPEPTIDASE; CATHEPSIN G; CHONDROITIN SULFATE; CYTOKINE; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; LEUKOTRIENE C4; NEUTRAL PROTEINASE; PROSTAGLANDIN D2; THROMBOCYTE ACTIVATING FACTOR;

ALLERGIC REACTION; BASOPHIL; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; EOSINOPHIL; GRANULOPOIESIS; HOST RESISTANCE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

EID: 0031454007     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.22.1815     Document Type: Review

References (69)

1. Costa JJ, Galli SJ. Mast cells and basophils. In: Rich R, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology: Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996:408-430.
2. + pluripotent progenitor cells. J Immunol. 1992;148:772-777.
3. Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis, Mo: Mosby-Year Book Inc; 1993:135-168.
4. Valent P, Bettelheim P. The human basophil. Crit Rev Oncol Hematol. 1990;10:327-352.
5. Beaven MA, Metzger H. Signal transduction by Fc receptors. Immunol Today. 1993;14:222-226.
6. Kinet J-P. The high-affinity receptor for IgE. Curr Opin Immunol. 1989;2:499-505.
7. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol. 1994;55:1-96.
8. Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (c-kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med. 1996; 183:2681-2686.
9. Galli SJ. New insights into 'the riddle of the mast cells.' Lab Invest. 1990;62:5-33.
10. Kitamura Y. Heterogeneity of mast cells and phenotypic changes between subpopulations. Annu Rev Immunol. 1989;7:59-76.
11. Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today. 1989;10:381-386.
12. Church MK, Benyon RC, Rees PH, et al. Functional heterogeneity of human mast cells. In: Galli SJ, Austen KF, eds. Mast Cell and Basophil Differentiation and Function in Health and Disease. New York, NY: Raven Press; 1989:161-170.
13. Bienenstock J, Befus AD, Denburg JA. Mast cell heterogeneity. In: Befus AD, Bienenstock J, Denburg JA, eds. Mast Cell Differentiation and Heterogeneity. New York, NY: Raven Press; 1986: 391-402.
14. Galli SJ, Lichtenstein LM. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, eds. Allergy: Principles and Practice. 3rd ed. St Louis, Mo: Mosby-Year Book Inc; 1988:106-134.
15. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990;11:458-464.
16. Holgate ST, Robinson C, Church MK. Mediators of immediate hypersensitivity. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis, Mo: Mosby-Year Book Inc; 1993:267-301.
17. Galli SJ, Costa JJ. Mast cell-leukocyte cytokine cascades in allergic inflammation. Allergy. 1995;50: 851-862.
18. Valone FH, Boggs JM, Goetzl EJ. Lipid mediators of hypersensitivity and inflammation. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis, Mo: Mosby-Year Book Inc; 1993:302-319.
19. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol. 1994;94:427-438.
20. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
21. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257-265.
22. Wershil BK, Wang ZS, Gordon JR, et al. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest. 1991;87:446-453.
23. Wershil BK, Furuta GT, Wang Z-S, et al. Mast-cell dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology. 1996;110:1482-1490.
24. Kung TT, Stelts D, Zurcher JA, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol. 1995;12:404-409.
25. Costa JJ, Church MK, Galli SJ. Mast cell cytokines in allergic inflammation. In: Holgate ST, Busse W, eds. Inflammatory Mechanisms in Asthma. New York, NY: Marcel Dekker Inc; 1997:111-127.
26. Robinson DS, Durham SR, Kay AB. Cytokines, III: cytokines in asthma. Thorax. 1993;148:401-406.
27. Schleimer RP. Glucocorticosteroids: their mechanisms of action and use in allergic diseases. In: Middleton E Jr, Ellis EF, Adkinson NFJ, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis, Mo: Mosby-Year Book Inc; 1993: 893-925.
28. Wershil BK, Furuta GT, Lavigne JA, et al. Dexamethasone or cyclosporin A suppresses mast cell-leukocyte cytokine cascades. J Immunol. 1995; 154:1391-1398.
29. Gauchet JF, Henchoz S, Mazzei G, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 1993;365:340-343.
30. Lin S, Ciccala C, Scharenberg AM, et al. The FceRIb subunit functions as an amplifier of Fc∈RIg-mediated cell activation signals. Cell 1996;85:985-995.
31. Dembo M, Goldstein B, Sobotka AK, et al. Degranulation of human basophils. J Immunol. 1979; 123:1864-1872.
32. Conroy MC, Adkinson NF Jr, Lichtenstein LM. Measurement of IgE on human basophils. J Immunol. 1977;118:1317-1321.
33. Stallman PJ, Aalberse RC, Bruhl PC, et al. Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol. 1977;54: 364-373.
34. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell Fc∈RI expression in vitro and in vivo. J Exp Med. 1997;185:663-672.
35. Yano K, Yamaguchi M, de Mora F, et al. Production of macrophage inflammatory protein-1α by human mast cells. Lab Invest. 1997;77:185-193.
36. MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of Fc∈RI-expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol. 1997; 158:1438-1445.
37. Lemanske RFJ, Kaliner MA. Late phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis, Mo: Mosby-Year Book Inc; 1993:320-361.
38. Galli SJ, Wershil BK. The two faces of the mast cell. Nature. 1996;381:21-22.
39. Reed ND. Function and regulation of mast cells in parasite infections. In: Galli SJ, Austen KF, eds. Mast Cell and Basophil Differentiation and Function in Health and Disease. New York, NY: Raven Press; 1989:205-215.
40. Matsuda H, Watanabe N, Kiso Y, et al. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J Immunol. 1990;144:259-262.
41. Steeves EB, Allen JR. Basophils in skin reactions of mast cell-deficient mice infested with Dermacentor variabilis. Int J Parasitol. 1990;20:655-667.
42. Brown SJ, Galli SJ, Gleich GJ, et al. Ablation of immunity to Amblyomma americanum by antibasopnil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol. 1982;129:790-796.
43. Weller PF, Dvorak AM. Human eosinophils development, maturation and functional morphology. In: Busse W, Holgate ST, eds. Asthma and Rhinitis. Boston, Mass: Blackwell Scientific Publications; 1994:225-274.
44. Bozza PT, Yu W, Penrose JF, Dvorak AM, Weller PF. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J Exp Med. 1997;186:909-920.
45. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 1992;79:3101-3109.
46. Collins PD, Marleau S, Jose PJ, et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182:1169-1174.
47. Capron M, Soussi Gounni A, Morita M, et al. Eosinophils: from low-to high-affinity immunoglobulin E receptors. Allergy. 1995;50(suppl 25):20-23.
48. Humbert M, Grant JA, Taborda-Barata L, et al. High-affinity IgE receptor (Fc∈RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Resp Crit Care Med. 1996;153:1931-1937.
49. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, et al. IgA-induced eosinophil degranulation. J Immunol. 1989;142:2393-2400.
50. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Resp Cell Mol Biol. 1993;8: 349-355.
51. Wein M, Sterbinsky SA, Bickel CA, et al. Comparison of human eosinophil and neutrophil ligands for P-selectin: ligands for P-selectin differ from those for E-selectin. Am J Respir Cell Mol Biol. 1995;12:315-319.
52. Weller PF, Rand TH, Goelz SE, et al. Human eosinophil adherence to vascular endothelium mediated by binding to VCAM-1 and ELAM-1. Proc Natl Acad Sci U S A. 1991;88:7430-7433.
53. Bochner BS, Luscinskas FW, Gimbrone MAJ, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 1991;173:1553-1557.
54. Rott LS, Briskin MJ, Andrew DP, et al. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal cell adhesion molecule-1. J Immunol. 1996;156:3727-3736.
55. Weg VB, Williams TJ, Lobb RR, et al. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med. 1993;177:561-566.
56. Pretolani M, Ruffie C, Lapa e Silva JR, et al. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med. 1994;180:795-805.
57. Abraham WM, Sielczak MW, Ahmed A, et al. Anti-a4 intergrin mediates antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest. 1994;93:776-787.
58. Weller PF, Rand TH, Barrett T, et al. Accessory cell function of human eosinophils: HLA-DR dependent, MHC-restricted antigen-presentation and interleukin-1α formation. J Immunol. 1993;150:2554-2562.
59. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986; 39:177-253.
60. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85-101.
61. Weller PF. The immunobiology of eosinophils. N Engl J Med. 1991;324:1110-1118.
62. Weller PF. Lipid, peptide and cytokine mediators elaborated by eosinophils. In: Smith H, Cook M, eds. Immunopharmacology of Eosinophils: The Handbook of Immunopharmacology. London, England: Academic Press; 1993:25-42.
63. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol. 1994;94:1183-1188.
64. Desreumaux P, Capron M. Eosinophils in allergic reactions. Curr Opin Immunol. 1996;8:790-795.
65. Sedgwick JB, Quan SF, Calhoun WJ, et al. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy Clin Immunol. 1995;96:375-385.
66. Gounni AS, Lamkhioued B, Delaporte E, et al. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J Allergy Clin Immunol. 1994;94:1214-1216.
67. OhkawaraY, Lim KG, Xing Z, et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest. 1996;97:1761-1766.
68. Sher A, Coffman RL, Hieny S, et al. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol. 1990;145:3911-3916.
69. Herndon FJ, Kayes SG. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol. 1992;149:3642-3647.